Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cholecystokinin receptor type A (CCKAR), also known as CCK1 receptor, is a G-protein coupled receptor that plays crucial roles in both the gastrointestinal system and the central nervous system. This receptor has been extensively studied for its physiological functions and potential as a drug target. CCKAR primarily signals through the Gq protein pathway and is predominantly expressed in the gastrointestinal tract. It is a major physiological mediator of various digestive functions. In the nervous system, CCKAR regulates satiety and feeding behavior. CCKAR has been implicated in various physiological and pathological conditions, including regulation of appetite and satiety, anxiety regulation, and pain perception.
Gq protein pathway activation leading to increased intracellular calcium levels
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholecystokinin Receptor Type A (CCKAR).